Feed / BMRN

BioMarin Pharmaceutical Inc.

BMRN

Healthcare · 66.68 -1.5% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

BioMarin Pharmaceutical Inc.'s move is being confirmed by its market group.

BMRN accounts for 18.4% of the group's measured movement across 7.8 effective names. raw member direction is mixed; 6 of 12 SPY-adjusted paths align to the downside. Capital-flow agreement is 41%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

SPY-adjusted 5m paths
Role in the moveAligned contributor#1 of 12 by movement share
Group movement share18.4%Absolute path energy—not portfolio weight
Relative path-1.28%aligned
Effective breadth7.8 / 12broad
Relative alignment6/12downside path · 4 counter-moving
Capital-flow agreement41%not yet clean
SEQUENCE READ

EXEL, BMY, NBIX moved materially before BMRN. BMRN crossed its material path threshold at 12:15 ET, 95 minutes after the first measured mover. REGN, HALO followed.

What changed
  • Revenue increased 19.9% versus the comparable filing period.
  • Operating margin fell 22.3 percentage points.
EVIDENCE COVERAGE

8 of 15 members in Biopharmaceuticals and Care are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 10 of 15 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ABBV begins moving with the group.

Invalidation: The live read weakens if participation falls to 5 of 15 members or fewer.

Watch this read

Who this business touches

The relationships behind BMRN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

SNYSanoficustomerFeb 26, 2026 ▾

“Sanofi is our sole customer for ALDURAZYME and is responsible for distributing, marketing, and selling ALDURAZYME to third parties.”

SNYSanofidistributorMay 5, 2026 ▾

“PALYNZIQ is distributed in the U.S.”

Depended on by

SRPTSarepta Therapeutics, Inc.partnerMar 2, 2026 ▾

“1 to License Agreement between Sarepta Therapeutics, Inc.”

Filing peers

BCRXSRRKQURE

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 28 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

BMRN is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.